Checkpoint Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Fortress Biotech, Inc.(9.8%)
Checkpoint Therapeutics | 4:持股变动声明-股东 Fortress Biotech, Inc.
Checkpoint Therapeutics | EFFECT:其他
Checkpoint Therapeutics | UPLOAD:其他
Checkpoint Therapeutics | CORRESP:信函
Checkpoint Therapeutics | S-3:特定交易注册声明
Checkpoint Therapeutics | 10-Q:2024财年二季报
Checkpoint Therapeutics | 8-K:Checkpoint Therapeutics公布2024年第二季度财务业绩和最近的公司动态
Checkpoint Therapeutics | 8-K:重大事件
Checkpoint Therapeutics | D:发行公告
Checkpoint Therapeutics | 8-K:重大事件
Checkpoint Therapeutics | 424B5:募资说明书
Checkpoint Therapeutics | 4:持股变动声明-高管 Oliviero James F III
Checkpoint Therapeutics | 4:持股变动声明-高管 GRAY WILLIAM GARRETT
Checkpoint Therapeutics | 8-K:重大事件
Checkpoint Therapeutics | 4:持股变动声明-高管 GRAY WILLIAM GARRETT
Checkpoint Therapeutics | 4:持股变动声明-高管 Oliviero James F III
Checkpoint Therapeutics | S-8:员工福利计划证券登记
Checkpoint Therapeutics | 3:首次持股声明-股东 Fortress Biotech, Inc.
Checkpoint Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Fortress Biotech, Inc.(11.2%)
暂无数据
暂无数据